Patents Assigned to DEVELOPMENT FOUNDATION
  • Patent number: 9735886
    Abstract: Coherent reconstruction of dual polarized data and pilot signals without local oscillator or laser.
    Type: Grant
    Filed: September 2, 2015
    Date of Patent: August 15, 2017
    Assignee: Technion Research and Development Foundation Ltd.
    Inventors: Moshe Nazarathy, Amos Agmon, Alex Tolmachev
  • Patent number: 9735306
    Abstract: A photoelectrode, photovoltaic device and photoelectrochemical cell and methods of making are disclosed. The photoelectrode includes an electrode at least partially formed of FeO combined with at least one of lithium, hydrogen, sodium, magnesium, manganese, zinc, and nickel. The electrode may be doped with at least one of lithium, hydrogen, and sodium. The electrode may be alloyed with at least one of magnesium, manganese, zinc, and nickel.
    Type: Grant
    Filed: May 21, 2013
    Date of Patent: August 15, 2017
    Assignees: THE TRUSTEES OF PRINCETON UNIVERSITY, TECHNION RESEARCH & DEVELOPMENT FOUNDATION, LTD
    Inventors: Emily Ann Carter, Maytal Caspary Toroker
  • Patent number: 9731033
    Abstract: The present invention provides HIV-derived lentivectors which are safe, highly efficient, and very potent for expressing transgenes for human gene therapy, especially, in human hematopoietic progenitor cells as well as in all other blood cell derivatives. The lentiviral vectors comprise a self-inactivating configuration for biosafety and promoters such as the EF1? promoter as one example. Additional promoters are also described. The vectors can also comprise additional transcription enhancing elements such as the wood chuck hepatitis virus post-transcriptional regulatory element. These vectors therefore provide useful tools for genetic treatments such as inherited and acquired lympho-hematological disorders, gene-therapies for cancers especially the hematological cancers, as well as for the study of hematopoiesis via lentivector-mediated modification of human HSCs.
    Type: Grant
    Filed: September 12, 2016
    Date of Patent: August 15, 2017
    Assignee: Research Development Foundation
    Inventors: Didier Trono, Patrick Salmon
  • Publication number: 20170224618
    Abstract: Compositions comprising liposomes composed of whole cell membrane fraction are provided. The liposomes may be attached to, or encapsulate a pharmaceutical agent. Also provided are methods of generating and using these liposomes.
    Type: Application
    Filed: April 27, 2017
    Publication date: August 10, 2017
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Marcelle MACHLUF, Tomer BRONSHTEIN
  • Patent number: 9726536
    Abstract: A fiber optical superconducting nanowire detector with increased detector efficiency, fabricated directly on the tip of the input optical fiber. The fabrication on the tip of the fiber allows precise alignment of the detector to the fiber core, where the field mode is maximal. This construction maximizes the coupling efficiency to close to unity, without the need for complex alignment procedures, such as the need to align the input fiber with a previously fabricated device. The device includes a high-Q optical cavity, such that any photon entering the device will be reflected to and fro within the cavity numerous times, thereby increasing its chances of absorption by the nanowire structure. This is achieved by using dedicated cavity mirrors with very high reflectivity, with the meander nanowire structure contained within the cavity between the end mirrors, such that photons impinge on the nanowire structure with every traverse of the cavity.
    Type: Grant
    Filed: December 23, 2012
    Date of Patent: August 8, 2017
    Assignee: TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LIMITED
    Inventors: Gil Bachar, Oleg Shtempluck, Eyal Buks
  • Patent number: 9727650
    Abstract: A method and computing program for providing a user computing platform with a response to a query, the response comprising indications to one or more Universal Resource Identifier optionally with instructions on how to get the relevant information from there, and how to format the response. Thus a user computing platform receives information directly from a content provider, whose rights are not infringed by the query engine. If payment or other limitations are imposed by the content provider or by the user, they are handled between the user and the content provider, without intervention by the query engine.
    Type: Grant
    Filed: June 7, 2016
    Date of Patent: August 8, 2017
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Ran El-Yaniv, Roy Friedman
  • Patent number: 9718057
    Abstract: A microfluidic device includes a platform with a microstructure. The microstructure include a primary channel and a plurality of chambers that open to the primary channel to enable a sample fluid that is loaded into the device via the primary channel to flow into the chambers. Each chamber has a volume that is less than tens of nanoliters and is connected by a vent to a secondary channel of the microstructure. A width of the vent is configured to enable a gas to escape from the chamber to the secondary channel while inhibiting flow of the sample fluid from the chamber into the secondary channel.
    Type: Grant
    Filed: January 15, 2014
    Date of Patent: August 1, 2017
    Assignee: TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD.
    Inventors: Shulamit Levenberg, Jonathan Shemesh
  • Publication number: 20170211076
    Abstract: This invention provides fusion proteins comprising consecutive amino acids which beginning at the amino terminus of the protein correspond to consecutive amino acids present in (i) a cytomegalovirus human MHC-restricted peptide, (ii) a first peptide linker, (iii) a human ?-2 microglobulin, (iv) a second peptide linker, (v) a HLA-A2 chain of a human MHC class I molecule, (vi) a third peptide linker, (vii) a variable region from a heavy chain of a scFv fragment of an antibody, and (viii) a variable region from a light chain of such scFv fragment, wherein the consecutive amino acids which correspond to (vii) and (viii) are bound together directly by a peptide bond or by consecutive amino acids which correspond to a fourth peptide linker, wherein the antibody from which the scFv fragment is derived specifically binds to mesothelin.
    Type: Application
    Filed: April 6, 2017
    Publication date: July 27, 2017
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Yoram REITER, Roy NOY, Kfir OVED
  • Publication number: 20170204168
    Abstract: The present invention concerns gp36 immunoreactive compositions for E. canis and gp 47 immunoreactive compositions for E. chaffeensis. In particular, epitopes for E. canis gp36 and E. chaffeensis gp 47 are disclosed. In certain embodiments, the immunoreactive compositions comprise tandem repeats having carbohydrate moieties.
    Type: Application
    Filed: March 27, 2017
    Publication date: July 20, 2017
    Applicant: Research Development Foundation
    Inventors: Jere W. McBRIDE, Christopher K. DOYLE
  • Patent number: 9709001
    Abstract: Hinge pins for use in a method of accessing a crankshaft within an internal combustion engine that includes: A) inserting a first hinge pivot of a first hinge pin into a first bore on a front side of the internal combustion engine and locking in place; B) inserting a second hinge pivot of a second hinge pin into a second bore on a rear side opposite from the front side of the internal combustion engine and locking in place; and C) rotating the upper block upward around an axis of rotation running through the first bore and the second bore to expose a cavity between the upper block and the lower block to allow access to the crankshaft.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: July 18, 2017
    Assignee: GLOBAL IP DEVELOPMENT FOUNDATION
    Inventor: Kenneth Michael Buck
  • Publication number: 20170198046
    Abstract: A composition-of-matter comprising an antibody or antibody fragment including an antigen-binding region capable of specifically binding an antigen-presenting portion of a complex composed of a human antigen-presenting molecule and an antigen is disclosed.
    Type: Application
    Filed: March 23, 2017
    Publication date: July 13, 2017
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Yoram REITER, Galit DENKBERG, Cyril COHEN
  • Publication number: 20170201658
    Abstract: Imaging apparatus (26) includes an image sensor (30), configured to capture an image of radiation at a target wavelength that is incident on a front surface of the image sensor. A metasurface (28) having a negative permittivity and a negative permeability at the target wavelength is fixed to the front surface of the image sensor.
    Type: Application
    Filed: May 26, 2015
    Publication date: July 13, 2017
    Applicant: TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
    Inventors: Gilad Rosenblatt, Meir Orenstein
  • Patent number: 9701719
    Abstract: Novel attenuating deletions of Chikungunya virus E2 polypeptides are provided as are attenuated viruses comprising the deletions. Also provided are immunogenic compositions comprising the attenuated viruses and methods of producing such viruses in cells (such as insect cells). Viruses of the embodiments can be used for immunization of animals to provide protection from the pathogenic effects of Chikungunya virus infection.
    Type: Grant
    Filed: September 26, 2013
    Date of Patent: July 11, 2017
    Assignee: Research Development Foundation
    Inventors: Dennis T. Brown, Raquel Hernandez
  • Patent number: 9695410
    Abstract: Provided are isolated complexes comprising a major histocompatibility complex (MHC) class II and a type I diabetes-associated GAD autoantigenic peptide, the isolated complex having a structural conformation which enables isolation of a high affinity entity which comprises an antigen binding domain capable of specifically binding to a native conformation of a complex composed of the MHC class II and the type I diabetes-associated GAD autoantigenic peptide; and isolated high affinity entities comprising an antigen binding domain capable of specifically binding the complex, wherein the isolated high affinity entity does not bind to the MHC class II in an absence of the diabetes-associated GAD autoantigenic peptide, wherein the isolated high affinity entity does not bind to the diabetes-associated GAD autoantigenic peptide in an absence of the MHC class II; and methods and kits using same for diagnostic and therapeutic purposes.
    Type: Grant
    Filed: July 14, 2011
    Date of Patent: July 4, 2017
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Yoram Reiter, Rony Dahan
  • Patent number: 9696311
    Abstract: Sensor array for detecting biomarkers for cancer in breath samples. The sensor array is based on 2D films or 3D assemblies of conductive nanoparticles capped with an organic coating wherein the nanoparticles are characterized by a narrow size distribution. Methods of use of the sensor array for discriminating between patterns of volatile organic compounds from healthy individuals and patients with various types of cancer are disclosed.
    Type: Grant
    Filed: January 10, 2010
    Date of Patent: July 4, 2017
    Assignee: Technion Research and Development Foundation Ltd.
    Inventors: Hossam Haick, Peng Gang, Orna Adams
  • Patent number: 9693994
    Abstract: In some aspects, methods for treating a bacterial infection in a mammalian subject are provided. In some embodiments, a class IIa HDAC inhibitor such as, e.g., a HDAC4 inhibitor, may be used to treat a bacterial infection such as, e.g., anthrax, pertussis, tuberculosis, or cholera.
    Type: Grant
    Filed: April 9, 2015
    Date of Patent: July 4, 2017
    Assignee: Research Development Foundation
    Inventor: Marc Montminy
  • Publication number: 20170182078
    Abstract: A new class of pseudo-trisaccharide aminoglycosides having an alkyl group at the 5? position, exhibiting efficient stop codon mutation readthrough activity, low cytotoxicity and high selectivity towards eukaryotic translation systems are provided. Also provided are pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic disorders, as well as processes of preparing these aminoglycosides. The disclosed aminoglycosides can be represented by the general formula I: or a pharmaceutically acceptable salt thereof, wherein R1 is selected from the group consisting of alkyl, cycloalkyl and aryl; and all other variables and features are as described in the specification.
    Type: Application
    Filed: March 9, 2017
    Publication date: June 29, 2017
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Timor BAASOV, Dana ATIA-GLIKIN, Jeyakumar KANDASAMY, Valery BELAKHOV
  • Publication number: 20170183628
    Abstract: Provided is an isolated population of human pluripotent stem cells comprising at least 50% human pluripotent stem cells characterized by an OCT4+/TRA1-60?/TRA1-81?/SSEA1+/SSEA4? expression signature, and novel methods of generating and maintaining same in a pluripotent, undifferentiated state a suspension culture devoid of cell clumps. Also provided are novel culture media, cell cultures and methods for culturing pluripotent stem cells in a suspension culture or a two-dimensional culture system while maintaining the cells in a proliferative, pluripotent and undifferentiated state. The novel culture media comprise interleukin 11 (IL11) and Ciliay Neurotrophic Factor (CNTF); bFGF at a concentration of at least 50 ng/ml and an IL6RIL6 chimera; or an animal contaminant-free serum replacement and an IL6RIL6 chimera. Also provided are methods for generating lineage-specific cells from the pluripotent stem cells.
    Type: Application
    Filed: January 11, 2017
    Publication date: June 29, 2017
    Applicant: Technion Research & Development Foundation Limited
    Inventors: Michal AMIT, Joseph ITSKOVITZ-ELDOR
  • Patent number: 9689826
    Abstract: The present invention provides a sensor or a system comprising gold nanoparticles coated with specific organic coatings for diagnosing, staging or monitoring chronic kidney disease.
    Type: Grant
    Filed: March 11, 2013
    Date of Patent: June 27, 2017
    Assignee: Technion Research and Development Foundation Ltd.
    Inventors: Hossam Haick, Ophir Marom
  • Publication number: 20170173136
    Abstract: The present invention concerns gp19 immunoreactive compositions for E. canis and compositions related thereto, including vaccines, antibodies, polypeptides, peptides, and polynucleotides. In particular, epitopes for E. canis gp19 are disclosed.
    Type: Application
    Filed: February 27, 2017
    Publication date: June 22, 2017
    Applicant: Research Development Foundation
    Inventors: Jere W. McBRIDE, Christopher Kuyler DOYLE